Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

LUN96-1

A Phase II Study of Paclitaxel (3-Hour Infusion and Bolus Doxorubicin in Recurrent or Refractory Small Cell Lung Cancer

Abstracts/Posters/Presentations:

  • Sonpavde G, Ansari R, Einhorn L. A Phase II Trial of Bolus Doxorubicin and 3-Hour Paclitaxel as Second-Line Chemotherapy of Small-Cell Lung Cancer: A Hoosier Oncology Group Trial. A Hoosier Oncology Group Trial LUN96-1. Accepted to the ASCO annual meeting May 16-19, 1998, Los Angeles, CA.

Manuscripts/Articles:

  • Sonpavde G, Ansari R, Walker P, Sciortino D, Gabrys G, Murdock A, Gonin R, Einhorn L. Phase II Study of Doxorubicin and Paclitaxel as Second-Line Chemotherapy of Small-Cell Lung Cancer: A Hoosier Oncology Group Trial LUN96-1. American Journal of Clinical Oncology. 23(1):68-70, 2000 Feb.